2018
|
|

Abstract: The presence or development of WBC antibodies had no demonstrable effect on any clinical aspect of granulocyte transfusion therapy. It appears that, at least in the patient population studied, there is no evidence suggesting need for concern about recipient WBC alloimmunization when prescribing granulocyte transfusions.

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
0
6
0

Publication Types

Select...

Relationship

0
0

Authors

Journals